Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
19.43
+0.80 (4.29%)
At close: May 12, 2025, 4:00 PM
19.43
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Cidara Therapeutics Employees
Cidara Therapeutics had 38 employees as of December 31, 2024. The number of employees decreased by 31 or -44.93% compared to the previous year.
Employees
38
Change (1Y)
-31
Growth (1Y)
-44.93%
Revenue / Employee
$7,947
Profits / Employee
-$4,815,289
Market Cap
212.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CDTX News
- 2 days ago - Cidara Therapeutics, Inc. (CDTX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 7 days ago - Cidara Therapeutics: Strong Buy On Imminent Data Readout For Lead Flu Candidate - Seeking Alpha
- 11 days ago - Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development - GlobeNewsWire
- 12 days ago - Cidara Therapeutics to Participate in The Citizens Life Sciences Conference - GlobeNewsWire
- 18 days ago - Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025 - GlobeNewsWire
- 26 days ago - Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire